vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and TRIMAS CORP (TRS). Click either name above to swap in a different company.
TRIMAS CORP is the larger business by last-quarter revenue ($256.5M vs $208.9M, roughly 1.2× iRhythm Holdings, Inc.). TRIMAS CORP runs the higher net margin — 31.9% vs 2.7%, a 29.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 3.8%). TRIMAS CORP produced more free cash flow last quarter ($36.8M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 3.3%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Trimas Corp is a diversified industrial manufacturing enterprise that designs, produces and distributes a wide portfolio of engineered products, including specialized fasteners, aerospace components, custom packaging solutions, and consumer & industrial hardware. It primarily serves aerospace, automotive, construction, consumer goods and industrial sectors, with core operations across North America and selected global markets.
IRTC vs TRS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $256.5M |
| Net Profit | $5.6M | $81.7M |
| Gross Margin | 70.9% | 12.8% |
| Operating Margin | 1.1% | 5.7% |
| Net Margin | 2.7% | 31.9% |
| Revenue YoY | 27.1% | 3.8% |
| Net Profit YoY | 518.5% | 236.9% |
| EPS (diluted) | $0.18 | $2.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $256.5M | ||
| Q4 25 | $208.9M | $-140.0M | ||
| Q3 25 | $192.9M | $269.3M | ||
| Q2 25 | $186.7M | $274.8M | ||
| Q1 25 | $158.7M | $241.7M | ||
| Q4 24 | $164.3M | $-66.2M | ||
| Q3 24 | $147.5M | $229.4M | ||
| Q2 24 | $148.0M | $240.5M |
| Q1 26 | — | $81.7M | ||
| Q4 25 | $5.6M | $81.7M | ||
| Q3 25 | $-5.2M | $9.3M | ||
| Q2 25 | $-14.2M | $16.7M | ||
| Q1 25 | $-30.7M | $12.4M | ||
| Q4 24 | $-1.3M | $5.6M | ||
| Q3 24 | $-46.2M | $2.5M | ||
| Q2 24 | $-20.1M | $10.9M |
| Q1 26 | — | 12.8% | ||
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | 12.8% | ||
| Q2 25 | 71.2% | 13.8% | ||
| Q1 25 | 68.8% | 13.6% | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | 15.4% | ||
| Q2 24 | 69.9% | 14.4% |
| Q1 26 | — | 5.7% | ||
| Q4 25 | 1.1% | — | ||
| Q3 25 | -4.4% | 6.2% | ||
| Q2 25 | -10.0% | 9.9% | ||
| Q1 25 | -20.5% | 9.0% | ||
| Q4 24 | -2.5% | — | ||
| Q3 24 | -34.1% | 3.6% | ||
| Q2 24 | -15.5% | 7.4% |
| Q1 26 | — | 31.9% | ||
| Q4 25 | 2.7% | -58.4% | ||
| Q3 25 | -2.7% | 3.5% | ||
| Q2 25 | -7.6% | 6.1% | ||
| Q1 25 | -19.3% | 5.1% | ||
| Q4 24 | -0.8% | -8.5% | ||
| Q3 24 | -31.3% | 1.1% | ||
| Q2 24 | -13.6% | 4.5% |
| Q1 26 | — | $2.03 | ||
| Q4 25 | $0.18 | $2.01 | ||
| Q3 25 | $-0.16 | $0.23 | ||
| Q2 25 | $-0.44 | $0.41 | ||
| Q1 25 | $-0.97 | $0.30 | ||
| Q4 24 | $-0.03 | $0.14 | ||
| Q3 24 | $-1.48 | $0.06 | ||
| Q2 24 | $-0.65 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $30.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $705.6M |
| Total Assets | $1.0B | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $30.0M | ||
| Q4 25 | $583.8M | $30.0M | ||
| Q3 25 | $565.2M | $33.6M | ||
| Q2 25 | $545.5M | $30.3M | ||
| Q1 25 | $520.6M | $32.7M | ||
| Q4 24 | $535.6M | $23.1M | ||
| Q3 24 | $522.0M | $26.9M | ||
| Q2 24 | $561.5M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $469.2M | ||
| Q3 25 | — | $407.1M | ||
| Q2 25 | — | $424.5M | ||
| Q1 25 | — | $434.2M | ||
| Q4 24 | — | $398.1M | ||
| Q3 24 | — | $409.9M | ||
| Q2 24 | — | $427.4M |
| Q1 26 | — | $705.6M | ||
| Q4 25 | $152.7M | $705.6M | ||
| Q3 25 | $121.9M | $725.0M | ||
| Q2 25 | $103.7M | $715.3M | ||
| Q1 25 | $86.7M | $686.6M | ||
| Q4 24 | $90.9M | $667.3M | ||
| Q3 24 | $71.8M | $682.8M | ||
| Q2 24 | $99.2M | $675.9M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $995.2M | $1.4B | ||
| Q2 25 | $964.0M | $1.4B | ||
| Q1 25 | $926.1M | $1.4B | ||
| Q4 24 | $931.4M | $1.3B | ||
| Q3 24 | $909.7M | $1.4B | ||
| Q2 24 | $919.2M | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | 0.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $117.5M |
| Free Cash FlowOCF − Capex | $14.5M | $36.8M |
| FCF MarginFCF / Revenue | 6.9% | 14.4% |
| Capex IntensityCapex / Revenue | 5.6% | 18.9% |
| Cash ConversionOCF / Net Profit | 4.70× | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $109.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $117.5M | ||
| Q4 25 | $26.2M | $41.5M | ||
| Q3 25 | $34.9M | $36.5M | ||
| Q2 25 | $27.7M | $30.3M | ||
| Q1 25 | $-7.9M | $9.2M | ||
| Q4 24 | $19.2M | $27.1M | ||
| Q3 24 | $24.3M | $22.0M | ||
| Q2 24 | $11.8M | $18.4M |
| Q1 26 | — | $36.8M | ||
| Q4 25 | $14.5M | $36.8M | ||
| Q3 25 | $20.1M | $22.8M | ||
| Q2 25 | $17.3M | $13.2M | ||
| Q1 25 | $-17.3M | $-3.8M | ||
| Q4 24 | $12.4M | $12.1M | ||
| Q3 24 | $15.5M | $10.2M | ||
| Q2 24 | $3.4M | $7.5M |
| Q1 26 | — | 14.4% | ||
| Q4 25 | 6.9% | -26.3% | ||
| Q3 25 | 10.4% | 8.5% | ||
| Q2 25 | 9.3% | 4.8% | ||
| Q1 25 | -10.9% | -1.6% | ||
| Q4 24 | 7.5% | -18.3% | ||
| Q3 24 | 10.5% | 4.4% | ||
| Q2 24 | 2.3% | 3.1% |
| Q1 26 | — | 18.9% | ||
| Q4 25 | 5.6% | -3.4% | ||
| Q3 25 | 7.7% | 5.1% | ||
| Q2 25 | 5.6% | 6.2% | ||
| Q1 25 | 5.9% | 5.4% | ||
| Q4 24 | 4.2% | -22.6% | ||
| Q3 24 | 6.0% | 5.2% | ||
| Q2 24 | 5.7% | 4.5% |
| Q1 26 | — | 1.44× | ||
| Q4 25 | 4.70× | 0.51× | ||
| Q3 25 | — | 3.92× | ||
| Q2 25 | — | 1.81× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 4.80× | ||
| Q3 24 | — | 8.71× | ||
| Q2 24 | — | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
TRS
Segment breakdown not available.
